Mabqi uses its proprietary phage display technology to deliver to our customers antibodies with the desired characteristics, fit for continued drug development.
Each project is assigned to a dedicated team, focused on a single target at a time, to configure project plans and antibody selection schemes adjusted to the antigen and objectives.
Mabqi works in tandem with its corresponding academic platform “GenAc” and Inserm lab for very active research and R&D collaboration to continuously improve and innovate in our methods and tools.
Our team consolidates management excellence and best in class scientific expertise that can be traced back to the founding of fully human antibody phage display libraries.
Founder / Chief Executive Officer
20 years of experience in medical devices and biotechnology startups. Sylvain is an active business angel and strategic consultant for some very promising ventures in healthcare. He holds an engineering degree from ESPCI ParisTech and a PhD from Paris Diderot University.